🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
3.780
-0.050 (-1.31%)
At close: Nov 20, 2026, 4:00 PM EST
3.909
+0.129 (3.42%)
After-hours: Nov 20, 2026, 7:51 PM EST

Artiva Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
61.2326.740.2453.5102.53160.92
Short-Term Investments
257.8781.31145.1923.47--
Cash & Short-Term Investments
319.1108.01185.4376.97102.53160.92
Cash Growth
159.50%-41.75%140.91%-24.93%-36.29%532.51%
Accounts Receivable
---1.030.530.47
Other Receivables
1.720.771.050.82--
Receivables
1.720.771.051.860.530.47
Prepaid Expenses
5.433.892.160.991.620.9
Total Current Assets
326.25112.67188.6379.82104.68162.29
Property, Plant & Equipment
14.9117.3620.4324.6427.624.08
Long-Term Deferred Charges
-----3.17
Other Long-Term Assets
1.810.920.530.650.760.39
Total Assets
342.98130.94209.58105.11133.05169.93

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2.040.361.120.611.11.44
Accrued Expenses
11.059.67.398.0210.1510.13
Current Portion of Leases
3.323.063.743.63.490.43
Current Unearned Revenue
----10.897.3
Other Current Liabilities
-0.07----
Total Current Liabilities
16.4113.0912.2512.2325.6319.31
Long-Term Leases
5.857.8810.6113.3215.961.31
Long-Term Unearned Revenue
----15.6421.68
Other Long-Term Liabilities
--0.0725.170.120.08
Total Liabilities
22.2620.9722.9450.7257.3442.37

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.0100---
Additional Paid-In Capital
729.85440.41433.4518.9911.94.95
Retained Earnings
-407.89-330.55-246.68-181.31-152.59-93.8
Comprehensive Income & Other
-1.250.1-0.130.31--
Total Common Equity
320.72109.97186.64-162.02-140.7-88.86
Shareholders' Equity
320.72109.97186.6454.475.72127.56
Total Liabilities & Equity
342.98130.94209.58105.11133.05169.93

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
9.1710.9414.3516.9119.451.74
Net Cash (Debt)
309.9397.07171.0760.0683.08159.18
Net Cash Growth
178.52%-43.26%184.84%-27.71%-47.81%582.42%
Net Cash Per Share
8.853.9715.1974.82108.36232.10
Filing Date Shares Outstanding
49.4324.7224.360.810.770.71
Total Common Shares Outstanding
49.2724.2924.290.810.770.71
Working Capital
309.8499.58176.3867.5979.05142.98
Book Value Per Share
6.514.537.68-200.07-183.50-124.96
Tangible Book Value
320.72109.97186.64-162.02-140.7-88.86
Tangible Book Value Per Share
6.514.537.68-200.07-183.50-124.96
Machinery
15.7214.2111.8811.24-2.78
Leasehold Improvements
0.960.870.410.39-0.04
SEC Filings: 10-K · 10-Q